Panretinal photocoagulation plus intravitreal bevacizumab versuspanretinal photocoagulation alone for proliferative diabetic retinopathy
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2018; 28 (12): 923-927
em Inglês
| IMEMR
| ID: emr-205234
ABSTRACT
Objective:
to compare panretinal photocoagulation [PRP] plus intravitreal bevacizumab [IVB] against PRP alone in the treatment of proliferative diabetic retinopathy [PDR] in terms of mean change in best corrected visual acuity [BCVA], neovessels on disc [NVD] and neovessels elsewhere [NVE]
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
J. Coll. Physicians Surg. Pak.
Ano de publicação:
2018
Similares
MEDLINE
...
LILACS
LIS